Read twice and referred to the Committee on Finance.
The bill amends Medicare law to clarify coverage and payment rules for home infusion therapy. It explicitly includes pharmacy and nursing services, allows nurse practitioners and physician assistants to establish and review infusion plans, defines certain non-pump intravenous antimicrobials as home infusion drugs, clarifies billing for those drugs, sets payment rules (including a transitional 5-hour-per-day benchmark and a 50% payment when a supplier is not physically present), and prohibits duplicate payment for certain supplies furnished the same day.
Liberal emphasizes access risks from 50% non‑presence payment rule
Relative to its intended legislative type, this bill translates a focused policy objective into concrete statutory amendments with good specificity and clear cross-references, but it lacks fiscal disclosure and formal accountability or oversight mechanisms that would fully round out implementation for a Medicare payment change.
The bill amends Medicare law to clarify coverage and payment rules for home infusion therapy.
It explicitly includes pharmacy and nursing services, allows nurse practitioners and physician assistants to establish and review infusion plans, defines certain non-pump intravenous antimicrobials as home infusion drugs, clarifies billing for those drugs, sets payment rules (including a transitional 5-hour-per-day benchmark and a 50% payment when a supplier is not physically present), and prohibits duplicate payment for certain supplies furnished the same day.
Most changes take effect January 1, 2026.
Narrow, technical Medicare adjustments often advance, but fiscal impact, CBO score, and packaging into larger legislation are decisive.
Relative to its intended legislative type, this bill translates a focused policy objective into concrete statutory amendments with good specificity and clear cross-references, but it lacks fiscal disclosure and formal accountability or oversight mechanisms that would fully round out implementation for a Medicare payment change.
Liberal emphasizes access risks from 50% non‑presence payment rule
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes access risks from 50% non‑presence payment rule
Overall supportive: the bill clarifies coverage and seeks to preserve patient access to home infusion services.
It expands team-based care by permitting NPs and PAs to establish and review plans, and ensures pharmacy services are recognized.
Concern will focus on the 50% payment when a supplier is not physically present and the prohibition on separate supply payments, which could reduce provider incentives and harm access for vulnerable patients.
Generally favorable as a technical fix that clarifies coverage and balances access with cost controls.
The bill attempts to prevent duplicate payments, clarifies billing for non-pump drugs, and expands care team roles.
Centrists will want implementation data, guardrails to prevent access gaps, and budget scoring to judge fiscal impact.
Cautiously supportive if the bill controls costs and reduces duplicate payments.
It tightens payment rules and clarifies coverage, which can reduce waste.
Some conservatives may worry the bill expands Medicare obligations by explicitly adding pharmacy services and new covered drugs, though the 50% payment rule and supply payment prohibition are viewed as reasonable cost controls.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, technical Medicare adjustments often advance, but fiscal impact, CBO score, and packaging into larger legislation are decisive.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes access risks from 50% non‑presence payment rule
Narrow, technical Medicare adjustments often advance, but fiscal impact, CBO score, and packaging into larger legislation are decisive.
Relative to its intended legislative type, this bill translates a focused policy objective into concrete statutory amendments with good specificity and clear cross-references, but it lacks fiscal disclosure and formal a…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.